Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian F Pollack

Showing results (171-180 of 308) with videos related to

Pageof 31
Sort By:
Epilepsia Open|October 6, 2023
Characterization of low-grade epilepsy-associated tumor from implanted stereoelectroencephalography electrodesTaylor A Gatesman, Jasmine L Hect, H Westley Phillips, et al.
Cancer|September 16, 2003
Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945Maryam Fouladi, Daniel L Hunt, Ian F Pollack, et al.
Neuro-Oncology|February 23, 2011
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupKenneth J Cohen, Ian F Pollack, Tianni Zhou, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Quantitative Sodium (<sup>23</sup>Na) MRI in Pediatric Gliomas: Initial ExperienceAashim Bhatia, Vincent Kyu Lee, Yongxian Qian, et al.
Neuro-Oncology|August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromasRegina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018Katherine E Warren, Stewart Goldman, Ian F Pollack, et al.
Neuro-Oncology|February 14, 2025
Immuno-epidemiologic mapping of HLA diversity across glioma patient cohortsZujian Xiong, Kyle M Walsh, Chaim T Sneiderman, et al.
Journal of Neuro-Oncology|July 8, 2010
Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Peter C Burger, et al.
Neuro-Oncology|December 19, 2015
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumorsMarina N Nikiforova, Abigail I Wald, Melissa A Melan, et al.
Journal of Neuro-Oncology|November 29, 2014
Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945David D Eisenstat, Ian F Pollack, Alain Demers, et al.
Pageof 31

Showing results (171-180 of 308) with videos related to

Sort By:
Pageof 31
Epilepsia Open|October 6, 2023
Characterization of low-grade epilepsy-associated tumor from implanted stereoelectroencephalography electrodesTaylor A Gatesman, Jasmine L Hect, H Westley Phillips, et al.
Cancer|September 16, 2003
Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945Maryam Fouladi, Daniel L Hunt, Ian F Pollack, et al.
Neuro-Oncology|February 23, 2011
Temozolomide in the treatment of high-grade gliomas in children: a report from the Children's Oncology GroupKenneth J Cohen, Ian F Pollack, Tianni Zhou, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Quantitative Sodium (<sup>23</sup>Na) MRI in Pediatric Gliomas: Initial ExperienceAashim Bhatia, Vincent Kyu Lee, Yongxian Qian, et al.
Neuro-Oncology|August 12, 2016
Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromasRegina I Jakacki, Eva Dombi, Seth M Steinberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 15, 2010
Phase I trial of lenalidomide in pediatric patients with recurrent, refractory, or progressive primary CNS tumors: Pediatric Brain Tumor Consortium study PBTC-018Katherine E Warren, Stewart Goldman, Ian F Pollack, et al.
Neuro-Oncology|February 14, 2025
Immuno-epidemiologic mapping of HLA diversity across glioma patient cohortsZujian Xiong, Kyle M Walsh, Chaim T Sneiderman, et al.
Journal of Neuro-Oncology|July 8, 2010
Akt activation is a common event in pediatric malignant gliomas and a potential adverse prognostic marker: a report from the Children's Oncology GroupIan F Pollack, Ronald L Hamilton, Peter C Burger, et al.
Neuro-Oncology|December 19, 2015
Targeted next-generation sequencing panel (GlioSeq) provides comprehensive genetic profiling of central nervous system tumorsMarina N Nikiforova, Abigail I Wald, Melissa A Melan, et al.
Journal of Neuro-Oncology|November 29, 2014
Impact of tumor location and pathological discordance on survival of children with midline high-grade gliomas treated on Children's Cancer Group high-grade glioma study CCG-945David D Eisenstat, Ian F Pollack, Alain Demers, et al.
Pageof 31